Aigen Investment Management’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-33,155
| Closed | -$155K | – | 802 |
|
|
2024
Q2 | $155K | Buy |
+33,155
| New | +$155K | 0.03% | 655 |
|
|
2024
Q1 | – | Sell |
-59,209
| Closed | -$600K | – | 758 |
|
|
2023
Q4 | $600K | Buy |
+59,209
| New | +$600K | 0.11% | 275 |
|
|
2023
Q3 | – | Sell |
-11,796
| Closed | -$97.1K | – | 895 |
|
|
2023
Q2 | $97.1K | Buy |
+11,796
| New | +$97.1K | 0.01% | 675 |
|
|
2021
Q3 | – | Sell |
-3,778
| Closed | -$214K | – | 528 |
|
|
2021
Q2 | $214K | Sell |
3,778
-6,115
| -62% | -$346K | 0.04% | 387 |
|
|
2021
Q1 | $416K | Buy |
+9,893
| New | +$416K | 0.06% | 332 |
|
|
2020
Q3 | – | Sell |
-18,495
| Closed | -$547K | – | 915 |
|
|
2020
Q2 | $547K | Buy |
+18,495
| New | +$547K | 0.07% | 432 |
|
|
2020
Q1 | – | Sell |
-3,262
| Closed | -$97K | – | 1330 |
|
|
2019
Q4 | $97K | Buy |
+3,262
| New | +$97K | 0.02% | 688 |
|